Line 2,369: |
Line 2,369: |
| !'''Notes''' | | !'''Notes''' |
| |- | | |- |
− | |'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera | + | | ||Disease|| |
| + | | |
| + | | |
| + | |PENDING |
| | | | | |
| | | | | |
− | |complete
| |
| | | | | |
− | |Fabiola Quintero-Rivera (FQR)
| |
− | |Date page was created
| |
| | | | | |
| |- | | |- |
− | | Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive||Disease | + | | |
− | |Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera | + | |Disease |
| + | | |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | | |
| | | | | |
| | | | | |
− | |complete
| |
| |- | | |- |
| |}<br /> | | |}<br /> |